NeuroPace Newswire (Page 2)

NeuroPace Newswire (Page 2)

Comprehensive Real-Time News Feed for NeuroPace. (Page 2)

Results 21 - 35 of 35 in NeuroPace

  1. Neuroprosthetics Market Size, Analysis, Growth and Demand Forecast to 2020 By P&S Market ResearchRead the original story

    Feb 9, 2016 | Emailwire.com

    ... market are Boston Scientific Corporation, Cyberonics Inc., Cochlear Limited, NDI Medical LLC, Nervo Corporation, NeuroPace Inc., Medtronic Inc., Aleva Neuroprosthetic, Oticon Medical, St Jude Medical, Retina Implant AG, and Sonova Group. GLOBAL ...

    Comment?

  2. For epilepsy patient, brain stimulation offers jolt of hopeRead the original story w/Photo

    Feb 6, 2016 | Milwaukee Journal-Sentinal

    ... causes his seizures emanates from. Unlike other forms of brain stimulation, the RNS system, made by the company NeuroPace , doesn't just deliver continuous electrical current. First, it looks for abnormal electrical activity. When abnormal activity ...

    Comment?

  3. QYResearch: Industry Analysis Report for Global Neuro Stimulation Devices Industry 2016Read the original story w/Photo

    Jan 24, 2016 | PR-inside.com

    ... Medtronic St. Jude Medical, Inc Boston Scientific Corporation Cyberonics, Inc. Cochlear, Ltd NDI Medical, LLC NeuroPace, Inc ... Tablet of contents 1 Industry Overview of Neuro Stimulation Devices 2 Manufacturing Cost Structure Analysis of Neuro ...

    Comment?

  4. Neurostimulation Devices Market - Increasing Prevalence of Chronic...Read the original story w/Photo

    Jan 22, 2016 | SBWire

    ... plc, St. Jude Medical, Inc., Boston Scientific Corporation, Cyberonics, Inc., Cochlear, Ltd., NDI Medical, LLC, NeuroPace, Inc., MED-EL, and NeuroSigma, Inc. These key market players have been profiled on the basis of attributes such as company ...

    Comment?

  5. Global Neuromodulation Devices Market Is Expected to Reach $9.3 Billion by 2021; Finds New ReportRead the original story w/Photo

    Jan 6, 2016 | SBWire

    ... Inc), Cyberonics, Inc (Livanova), The Magstim Company Ltd, Medtronic, Plc, Neurometrix, Inc, Neuronetics, Inc, Neuropace, Inc, Nevro Corp, St. Jude Medical, Inc, Synapse Biomedical, Inc Find more information Visit at: ...

    Comment?

  6. Research Report and Overview on Neurostimulation Market, 2015-2025Read the original story w/Photo

    Jan 5, 2016 | SBWire

    ... ostimulation market include Boston Scientific Corporation, Cyberonics Inc., St. Jude Medical Inc., Medtronic Inc., NeuroPace Inc., and NeuroSigma, Inc. Browse Full Report@

    Comment?

  7. Neurostimulation Devices Market Will Grow at a CAGR of 12.7% from...Read the original story w/Photo

    Jan 4, 2016 | SBWire

    ... devices market. Other major players of neurostimulation devices market include Cochlear, Ltd., NDI Medical, LLC, NeuroPace, Inc., NeuroSigma, Inc., and MED-EL. More Info: The global neurostimulation ...

    Comment?

  8. Global Neurostimulation Devices Market Will Grow US$ 10,445.7 Million by 2020 : PMRRead the original story w/Photo

    Dec 30, 2015 | SBWire

    ... devices market. Other major players of neurostimulation devices market include Cochlear, Ltd., NDI Medical, LLC, NeuroPace, Inc., NeuroSigma, Inc., and MED-EL. More Info: The global neurostimulation ...

    Comment?

  9. IQ4I Research & Consultancy Published a New Report on...Read the original story

    Dec 3, 2015 | PR.com

    ... are Neruonetics,Inc, Neurometrix, Cogentix Medical, Synapse Biomedical, Avery Biomedical, Nevro Corporation and Neuropace. Reasons for buying this report: Market assessment of all segments and sub segments of Neuromodulation devices market In-depth ...

    Comment?

  10. Neurostimulation Market Growth, Trends, Absolute Opportunity and...Read the original story

    Dec 2, 2015 | PR.com

    ... ostimulation market include Boston Scientific Corporation, Cyberonics Inc., St. Jude Medical Inc., Medtronic Inc., NeuroPace Inc., and NeuroSigma, Inc.

    Comment?

  11. SharpBrains Analysis Uncovers 10 Neurotechnologies About to Transform...Read the original story w/Photo

    Nov 11, 2015 | PRWeb

    ... disease), for example, to control home appliances via BCIs. A good number of companies, including Medtronic, Neuropace and St. Jude Medical, are developing systems to actively monitor brain activity and respond in real-time with appropriate ...

    Comment?

  12. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Nov 4, 2015 | Business Wire

    Mirroring will license the system and provide ... )--Cell Signaling Technology, Inc. , a worldwide provider of antibodies, announced today the release of 6 new monoclonal antibodies for tumor immunolo... )--Delivering on its commitment to provide the industry's most comprehensive identity and access management solution, SailPoint today announced that SecurityIQ is... )--NeuroPace, Inc. announced its RNS System received the industry's Most Promising New Product Award at the 2015 Phoenix Medical Device CEO Conference.

    Comment?

  13. Neuromodulation Market Worth $6.20 Billion by 2020Read the original story w/Photo

    Nov 4, 2015 | SBWire

    ... St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel). About MarketsandMarkets ...

    Comment?

  14. NeuroPace, Inc. RNS System Associated With Positive Effects In Memory ...Read the original story

    Oct 19, 2015 | BioSpace

    NeuroPace, Inc. today announced results published in Epilepsia , a peer-reviewed journal dedicated to epilepsy. The study's findings demonstrated that people treated with the RNS System showed no adverse effects on cognition.

    Comment?

  15. NeuroPace RNSA System Associated with Positive Effects In Memory and ...Read the original story

    Oct 20, 2015 | Freshnews

    NeuroPace, Inc. today announced results published in Epilepsia , a peer-reviewed journal dedicated to epilepsy. The study's findings demonstrated that people treated with the RNS System showed no adverse effects on cognition.

    Comment?